Home/Filings/4/0001185185-16-005492
4//SEC Filing

U.S. Stem Cell, Inc. 4

Accession 0001185185-16-005492

$USRMCIK 0001388319operating

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 4:03 PM ET

Size

7.6 KB

Accession

0001185185-16-005492

Insider Transaction Report

Form 4
Period: 2016-09-19
Comella Kristin C
Chief Science Officer
Transactions
  • Award

    Stock Options (right to buy)

    2016-09-19+1,500,0006,697,748 total
    Exercise: $0.02From: 2016-09-19Exp: 2026-09-19Common Stock (1,500,000 underlying)
  • Award

    Stock Options (right to buy)

    2016-09-19+5,000,0005,197,748 total
    Exercise: $0.02Exp: 2026-09-19Common Stock (5,000,000 underlying)
Footnotes (1)
  • [F1]1,250,000 vest on 09/19/2017, 1,250,000 vest on 09/19/2018, 1,250,000 vest on 09/19/2019, 1,250,000 vest on 09/19/2020

Issuer

U.S. Stem Cell, Inc.

CIK 0001388319

Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0001388319

Filing Metadata

Form type
4
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:03 PM ET
Size
7.6 KB